Compounded medications are custom-prepared by pharmacies to meet specific patient needsbut they are not the same as FDA-approved drugs
The same rebound effect has been seen with other chronic conditions (e.g., diabetes, etc.) that the GLP1 receptor agonist may have been managing
Case reports, observational studies, randomised controlled trials, systematic reviews, meta-analyses, and expert consensus statements were included without language restrictions
Start at a low dose and gradually increase the dosage
While human studies remain limited, the available animal research and anecdotal evidence suggest that BPC-157 may help: Support tendon and ligament regeneration Reduce inflammation and joint discomfort Accelerate post-cycle healing after heavy anabolic use Prevent soft-tissue injuries during high-volume training Still, athletes should be cautious: BPC-157 is not FDA-approved, and sourcing high-purity peptides from reputable suppliers is essential